Gstöttner Christoph, Nicolardi Simone, Haberger Markus, Reusch Dietmar, Wuhrer Manfred, Domínguez-Vega Elena
Leiden University Medical Center, Center for Proteomics and Metabolomics, the Netherlands.
Pharma Technical Development Penzberg, Roche Diagnostics GmbH, Penzberg, Germany.
Anal Chim Acta. 2020 Oct 16;1134:18-27. doi: 10.1016/j.aca.2020.07.069. Epub 2020 Aug 21.
Bispecific antibodies (BsAb) are next-generation, antibody-based pharmaceuticals which come with a great functional versatility and often a vast structural heterogeneity. Although engineering of the primary sequence of BsAbs guides the proper pairing of the different chains, several side products can often be observed contributing to the macroheterogeneity of these products. Furthermore, changes in the amino acid sequence can result in different protein modifications which can affect the properties of the antibody and further increase the structural complexity. A multi-methods approach can be used for the characterization of their heterogeneity but new analytical strategies are needed for a more accurate and in-depth analysis. Here, we present a combination of intact antibody and subunit-specific mass measurements using sheathless capillary electrophoresis-mass spectrometry for assessing the macro- and microheterogeneity of BsAbs. Two homologous BsAbs with the same bispecificity but slightly different amino acid sequences were analyzed. Intact measurements were performed using a positively coated capillary and a background electrolyte (BGE) consisting of 3% acetic acid. For intact BsAbs, the separation permitted the characterization of free light chains, homo- and heterodimers as well as incomplete assemblies. For subunit-specific measurements, BsAbs were hinge region cleaved using two different enzymes (SpeB and IdeS) followed by disulfide-bond reduction. The six different subunits (Lc1, Lc2, Fd'1, Fd'2, (Fc/2)1 and (Fc/2)2) were separated using the same positively-coated capillary and a BGE consisting of 20% acetic acid and 10% methanol. Mass measurements of hinge region cleaved antibodies were performed at isotopic resolution (resolving power 140000 at m/z 1100) for a more confident analysis of low abundance proteoforms. For both BsAbs several proteoforms with e.g. pyroglutamic acid (Pyro-Glu) or glycation which could not be properly assigned at the intact level, were accurately determined in the subunits showing the complementarity of both approaches.
双特异性抗体(BsAb)是新一代基于抗体的药物,具有很强的功能多样性,且结构往往存在很大的异质性。尽管对BsAb一级序列的工程改造可引导不同链的正确配对,但通常会观察到几种副产物,这些副产物导致了这些产品的宏观异质性。此外,氨基酸序列的变化会导致不同的蛋白质修饰,这可能会影响抗体的性质,并进一步增加结构复杂性。可以采用多种方法来表征其异质性,但需要新的分析策略来进行更准确、更深入的分析。在此,我们展示了一种结合完整抗体和亚基特异性质量测量的方法,使用无鞘毛细管电泳-质谱法来评估BsAb的宏观和微观异质性。分析了两种具有相同双特异性但氨基酸序列略有不同的同源BsAb。完整测量使用带正电荷涂层的毛细管和由3%乙酸组成的背景电解质(BGE)进行。对于完整的BsAb,这种分离方法能够表征游离轻链、同二聚体和异二聚体以及不完全组装体。对于亚基特异性测量,使用两种不同的酶(SpeB和IdeS)切割BsAb的铰链区,然后进行二硫键还原。使用相同的带正电荷涂层的毛细管和由20%乙酸和10%甲醇组成的BGE分离六种不同的亚基(Lc1、Lc2、Fd'1、Fd'2、(Fc/2)1和(Fc/2)2)。对铰链区切割后的抗体进行同位素分辨率(在m/z 1100处分辨率为140000)的质量测量,以便更可靠地分析低丰度蛋白变体。对于这两种BsAb,几种在完整水平无法正确归属的蛋白变体,如焦谷氨酸(Pyro-Glu)或糖化变体,在亚基水平上得到了准确测定,显示了两种方法的互补性。